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Abstract
Devising effective cost-containment strategies in public insurance programs requires understanding the distribution of health 
care spending and characteristics of high-cost enrollees. The aim was to characterize high-cost enrollees in a state’s public 
insurance program and determine whether expenditure inequality changes over time, or with changes in cost-sharing policies 
or program eligibility. We use 1999-2011 claims and enrollment data from the Alabama Children’s Health Insurance Program, 
ALL Kids. All children enrolled in ALL Kids were included in our study, including multiple years of enrollment (N = 1,031,600 
enrollee-months). We examine the distribution of costs over time, whether this distribution changes after increases in cost 
sharing and expanded eligibility, patient characteristics that predict high-cost status, and examine health services used by high-
cost children to identify what is preventable. The top 10% (1%) of enrollees account for about 65.5% (24.7%) of total program 
costs. Inpatient and outpatient costs are the largest components of costs incurred by high-cost utilizers. Non-urgent emergency 
department costs are a relatively small portion. Average expenditure increases over time, particularly after expanded eligibility, 
and the share of costs incurred by the top 10% and 1% increases slightly. Multivariable logistic regression results indicate 
that infants and older teens, Caucasian children, and those with chronic conditions are more likely to be high-cost utilizers. 
Increased cost sharing does not reduce cost concentration or average expenditure among high-cost utilizers. These findings 
suggest that identifying and targeting potentially preventable costs among high-cost utilizers are called for to help reduce 
costs in public insurance programs.
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Introduction
It is well established that overall health care expenditures in the 
United States are not uniformly distributed. One report from 
the Agency for Healthcare Research and Quality found that, 
among the US population, the top 5% of patients accounted for 
49.5% of all spending, and the top 1% for almost 22% of all 
spending.1 Concerns about continued growth in health care 
spending have generated discussions about “bending the curve” 
for health costs. However, standard approaches to cost contain-
ment aimed at all consumers, like premium increases, copay-
ment increases, or higher deductibles, may not be effective if 
health care expenditures are concentrated among a small pro-
portion of consumers.2 A better understanding of the distribu-
tion of costs among publically insured children is necessary to 
develop more viable approaches to cost containment.
The extant literature in this field has largely focused on 
cross-sectional analysis of distribution of costs over relatively 
short periods. For example, using Medical Expenditure Panel 
Survey (MEPS) for 1996 to 1998, McCormick et al found that 
the top 10% of child enrollees accounted for 69% of total pedi-
atric health spending,3 and using MEPS data for 2000 to 2001, 
Liptak et al found that the top 10% accounted for 54% of all 
costs.4 For Medicaid and CHIP child enrollees in 2002 to 2005, 
Kenney et al (2009) found that the highest 10% of enrollees 
accounted for 72% of all program expenditures, whereas 30% 
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of enrollees used no services at all.5 Similar cost concentrations 
have been found in studies focusing on children in public health 
programs in a single state, or special-needs children.6,7 We are 
not aware of any studies that have explored whether program-
matic changes such as increased cost-sharing or changes in eli-
gibility to include less disadvantaged families influence cost 
concentration. Nor are we aware of studies that have explored 
whether child characteristics that predict being a high-cost user 
in one period also predict being a persistent high-cost user.
Regarding cost sharing and cost concentration, much of the 
medical care provided to children is preventive care that parents 
may regard as relatively discretionary. Hence, a modest increase 
in premiums may mostly deter take-up or re-enrollment by chil-
dren in good health with minimal health expenses.5,8-10 
Furthermore, authors of one of the seminal RAND health insur-
ance studies posited that many children’s illnesses are “acute but 
self-limiting,” and may be sensitive to cost-sharing in the form 
of higher copayments.11 Their empirical results found that out-
patient visits among children were sensitive to higher copay-
ments, whereas inpatient visits were less so. Thus, increased 
cost sharing may increase inequality in health care spending if it 
reduces re-enrollment and health service utilization by low-cost 
users while having little impact on high-cost utilizers.
An expansion in eligibility that adds families that are less 
disadvantaged, both in terms of income and parental education, 
to the insurance pool should increase health care utilization and 
average enrollee costs across the board, as such families may 
be more conscious about acquiring preventive services for their 
children and willing to spend more in copayments on both low-
acuity care and high-acuity care. It is not clear, a priori, how 
this would affect cost concentration. However, if less disadvan-
taged families disproportionately utilize preventive and low-
acuity care, then this may reduce cost concentration.
In this study, we use detailed longitudinal claims data from 
the ALL Kids program and add to the literature in several 
ways. First, we examine the distribution of annual expendi-
tures and cost concentration over a 12-year period, during 
which there were programmatic changes such as copayment 
and premium increases, as well as an expansion of eligibility 
to children from more affluent families. Second, we examine 
the individual characteristics that predict being a high-cost 
enrollee in 1 enrollment year, as well as a high-cost enrollee in 
several consecutive years. Finally, we use detailed claims data 
to assess what health services high-cost enrollees are most 
likely to utilize, and what percent of these are potentially pre-
ventable. This study complements previous work by this 
research team on changes in enrollment, health service utiliza-
tion and average health expenditures following increased cost 
sharing and expansion in eligibility, and persistence of high 
costs for enrollees with specific chronic conditions.10,12-16
Methods
We use pooled claims data from 1999 to 2011 from ALL 
Kids–Alabama’s CHIP program. Alabama is one of 12 states 
with separate CHIP and Medicaid programs. At the start of 
our study period, ALL Kids coverage was available to 
Alabama residents under age 19 with family incomes 
between 100% and 200% of the federal poverty level (FPL). 
Enrollees face annual premiums and copayments that vary 
across 3 groups defined by family income and Native 
American status. Children in families with incomes 100% to 
150% of the FPL (termed the low-fee group) face lower lev-
els of cost sharing, whereas children in families with incomes 
150% to 200% of the FPL (termed the fee group) face higher 
levels of cost sharing. The third group, comprising primarily 
Native American children (“no fee group”), is federally 
exempt from all cost sharing. There are no upfront annual 
deductibles in the ALL Kids program, and out-of-pocket 
costs per year may not exceed 5% of the family income.17
The ALL Kids program underwent 2 major changes over 
our study period. In October 2003, ALL Kids raised premi-
ums and copayments for most non-preventive services. 
Thereafter, beginning in October 2009, the eligibility level 
was expanded to 300% of the FPL. These changes allow us 
to explore whether the distribution of costs changes follow-
ing increased cost sharing and expanding eligibility to chil-
dren from less disadvantaged families.
We investigated the share of expenditures incurred by the 
lower 90% of enrollees versus the 90th percentile and above 
(ie, top 10%) and 99th percentile and above (top 1%). This is 
done separately for 1999 to 2003 (ie, before the increase in 
cost sharing), 2004-2009 (ie, after the increased cost sharing 
but before expanded eligibility), and 2010-2011 (ie, after the 
eligibility expansion). Individual enrollees are classified 
based on their total claims-based expenditures, including 
those enrolled who had no claims. Observations for the top 
1% are also included in overall observations for the top 10%. 
In addition to the share of expenditure of each type, we also 
present the average per member per month (PMPM) costs 
incurred overall, and for service category, adjusted to 2011 
dollars.
We also compare socio-demographic characteristics of 
enrollees in the lower 90% versus the high-cost utilizers in 
the top 1% and 10% of the expenditure distribution. Children 
are considered high-cost utilizers during the fiscal year if 
they were among the top 1% or 10%, though the same child 
can be a high-cost utilizer in multiple fiscal years.
To characterize trends in the distribution of expenditures 
over time, we construct Gini coefficients for each fiscal year. 
The Gini coefficient is a measure of statistical dispersion 
conventionally used to measure inequality, and is indepen-
dent of unit of measure or absolute size of group.18-22 
Appendix A gives details about how they are constructed.
Furthermore, we estimate multivariable logistic regres-
sions to identify the characteristics associated with being a 
high-cost utilizer belonging in the top decile of the expendi-
ture distribution, and in the top percentile of the expenditure 
distribution. For each outcome category (ie, 10%, 1%), we 
estimate logistic models with 2 alternative sets of covariates: 
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(1) patient socio-demographic characteristics, and (2) patient 
socio-demographic characteristics plus previous enrollment 
plus previous years of being a high-cost utilizer. Thereafter, 
we leverage the longitudinal nature of our data to investigate 
what characteristics are associated with being a “persistent 
high utilizer,” namely, for 3 consecutive fiscal years or more. 
We present these latter results for the top 1% only. All results 
are presented in the form of “marginal effects”—that is, the 
percentage point change in the likelihood of being in the top 
10% (1%) associated with a specific characteristic.
Finally, we briefly summarize the specific conditions that 
account for the most spending among the top 1%, and 
whether any of these appear to be potentially preventable 
(Appendix B). This can help provide information to program 
administrators about areas that can be targeted for cost 
savings.
This study was approved by the institutional review board 
for use of secondary data.
Results
As shown in Table 1, in fiscal years (FYs) 1999 to 2003, the 
top decile accounted for 63.6% of all health expenditures in 
the ALL Kids program; the top 1% accounted for nearly 20% 
of total expenditures. After the increase in cost sharing (FYs 
2004-2009), the figures for the top 10% and top 1% were 
64.2% and 21.1%, respectively. After the expansion in eligi-
bility (FY 2010-2011), the corresponding figures were 65.5% 
and 24.7%. Figure 1 presents Gini coefficients calculated for 
each year from 1999 to 2011. The Gini coefficients range 
between 0.68 and 0.70, suggesting that the pattern of inequal-
ity in the distribution of health care expenditure does not 
change substantially over time.
For all 3 periods, inpatient and outpatient services are the 
2 highest categories of expenditures among the top 10%. 
Inpatient services account for the highest share of expendi-
tures for the top 1%. The share declines slightly following 
increased cost sharing, but increases again with expanded 
eligibility. In contrast, for non–high-cost utilizers (ie, those 
below the 90% percentile) the highest share of expenditures 
comes from outpatient claims, followed by dental claims and 
prescription drugs expenditure. Emergency department (ED) 
expenditures are a relatively small category for all groups, 
and its share is particularly small for the top 1%.
A more complete picture emerges when these numbers 
are taken in conjunction with the inflation-adjusted average 
PMPM expenditure in all categories. Overall, average 
PMPM expenditures increase for all groups of enrollees, but 
the increases are larger for the top 1%. For example, between 
FYs 1999 to 2003 and 2004 to 2009, average overall expen-
ditures for the lower 90% increase by 18% ($489 to $577) 
whereas those for the top 1% increase by 28% ($22 619 to 
$28 918). Noticeably, there is no growth in PMPM for inpa-
tient services for the lower 90%, and a 15% increase in 
PMPM for outpatient services. In contrast, for the top 1%, 
PMPM for inpatient services increases by 18% and for out-
patient services by 33%. From FYs 2004 to2009 to FY 2010 
to 2011, the average overall expenditure for the lower 90% 
also increases by 18% ($577 to $683), but that for the top 1% 
increases by almost 43% ($28 918 to $41 436), leading to a 
further concentration in spending among the most expensive 
enrollees. The PMPM expenditures for all services increase 
over time, but the dollar increases from FYs 2004 to 2009 to 
FYs 2010 to 2011 are sizably larger than the changes from 
FYs 1999 to 2003 to FYs 2004 to 2009. For example, inpa-
tient spending among the top 1% increases by 56.3% (from 
$16 748 to $26 182) across the 2 periods.
Table 2 presents descriptive statistics on socio- 
demographic characteristics. High-cost utilizers tend to be 
more concentrated among the youngest (0-1) and oldest (17-
19) ALL Kids enrollees. High-cost enrollees are more likely 
to be Caucasian, have a chronic disease, have been previ-
ously enrolled in ALL Kids, and have previously been in the 
top percentile or decile of program expenditures.
Table 3 shows the adjusted marginal effects for high-cost 
utilizers from multivariable logistic models. Note that, when 
modeling the likelihood of being a persistent 1% user (3 
years or more), covariates are measured at the first year of 
the spell. Chronic disease was a statistically significant pre-
dictor of being within the top 10% of expenditures. Although 
still positive and statistically significant, the magnitude of 
the effect for being in the top 1% was smaller, and for being 
a persistent top 1% was even smaller. Similarly, having pre-
viously been in the top 10% or top 1% of expenditures, as 
well as having previous ALL Kids enrollment were associ-
ated with being a high-cost utilizer, although again the mag-
nitudes were higher in models examining the likelihood of 
being in the top 10% as opposed to top 1% or persistent top 
1%. Age was also an important predictor, such that all age 
groups compared with the youngest children were less likely 
to be among the top 10% of utilizers, with the exception of 
older children aged 17 to 19 years. Notably, it is better to 
interpret effects of age from model 1—there are obvious col-
linearity issues in model 2 as the reference category of infants 
0 to 1 years old can neither have previous ALL Kids enroll-
ment nor have previously been in a high-expenditure cate-
gory. The general pattern appears to be that all children in 
age groups from 2 to 12 years are less likely to be high-cost 
compared with infants. However, 17- to 19-year-olds appear 
to have a somewhat higher likelihood than infants of being in 
the top 10%, though they are less likely to be in the top 1%. 
When it comes to persistently being in the top 1%, there is no 
significant difference between infants and 17- to 19-year-
olds (many of whom age out of ALL Kids over the 3 years), 
and 13- to 16-year-olds are actually more likely than infants 
to be in that category.
“Fee group” enrollees were less likely than “low-fee” 
group enrollees to belong to the top decile, and also slightly 
less likely to persistently be in the top percentile. No fee 
group enrollees were more likely to belong to both the top 
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Table 1. Comparison of the Health Expenditures by the Lower 90%, Top 10%, and Top 1% of ALL Kids Enrollees Over 3 Periods.
FYs 1999-2003 FYs 2004-2009 FYs 2010-2011
 90% Top 10% Top 1% 90% Top 10% Top 1% 90% Top 10% Top 1%
Total expenditures, % 36.4 63.6 19.8 35.8 64.2 21.1 34.5 65.5 24.7
Spending, %a
 Inpatient 0.4 30.3 62.5 0.3 29.5 57.9 0.4 32.4 63.2
 EDb 9.7 6.9 2.8 9.2 7.3 3.3 8.1 6.7 2.6
 Outpatient 47.5 37.3 20.8 46.4 34.8 21.7 46.9 32.9 20.1
 Dental 23.1 8.3 1.1 23.2 6.7 0.9 25.0 5.8 0.7
 Drugs 18.8 14.7 9.8 20.2 18.6 12.8 19.2 19.2 11.0
 Other 0.5 2.5 3.0 0.6 3.1 3.5 0.4 3.0 2.5
N
person-months
222 590 39 281 2619 467 289 82 464 5500 178 359 31 476 2098
Expenditures, $ (% change from previous period)
Overall PMPM expenditure $489
—
$4832
—
$22 619
—
$577
(18.0)
$5867
(21.4)
$28 918
(27.8)
$683
(18.4)
$7328
(24.9)
$41 436
(43.3)
 Inpatient $2 $1463 $14 127 $2
(0)
$1730
(18.2)
$16 748
(18.5)
$3
(50.0)
$2376
(37.3)
$26 182
(56.3)
 EDb 47 333 631 53
(12.8)
429
(28.8)
945
(49.7)
56
(5.6)
488
(13.7)
1057
(11.8)
 Outpatient 232 1800 4715 268
(15.5)
2042
(13.4)
6271
(33.0)
320
(19.4)
2410
(18.0)
8331
(32.0)
 Dental 113 403 253 134
(18.6)
393
(−2.5)
252
(−0.4)
170
(26.8)
427
(8.6)
281
(11.5)
 Drugs 92 712 2214 116
(26.1)
1090
(53.1)
3694
(66.8)
131
(12.9)
1410
(29.3)
4551
(23.2)
 Other 3 120 677 3
(0)
183
(52.5)
1008
(48.9)
3
(0)
217
(18.6)
1034
(2.5)
Note. All expenditures are adjusted to 2011 dollars using the Consumer Price Index. CPI. ED = emergency department; PMPM = per member per month; 
FY = fiscal year. Percentage changes in PMPM changes represent changes from the previous period for the specific cost-category.
aDenotes how the expenditures for each group of enrollees (lower 90%, top 10%, and top 1%) are distributed across the categories of health services.
bED use that did not lead to an inpatient admission.
Figure 1. The concentration of expenditures is illustrated from FY 1999 to FY 2011 by the Gini coefficient, a measure of equality.
Sen et al 5
decile, though their results for being in the top percentile are 
mixed. Expansion group enrollees were more likely to be in 
the top decile than low-fee group enrollees in model 1—
again, there are collinearity issues with this group and model 
2 as they only start in ALL Kids from 2010.
We also conducted several supplementary analyses (not 
shown) to explore persistence. For example, among infants 
initially in the top decile, 74.1% remained in the program the 
next year, but only 29.5% remained after 3 years. Of those 
who remained, 45.6% were still in the top decile the next 
year, but only 20% of those enrolled still remained in the top 
decile in later years.
In Appendix B, we present a summary of the inpatient 
diagnoses among the top 1% by year, and broadly categorize 
them into conditions that appear to be potentially prevent-
able, conditions that may be preventable but are outside the 
scope of ALL Kids as they relate to maternal prenatal health 
and health behaviors, and conditions that are not prevent-
able. We find that the majority of inpatient cases fall in the 
last category.
Discussion
We analyzed the distribution of individual health expendi-
tures in Alabama’s ALL Kids between 1999 to 2011, a period 
during which the program underwent changes in cost sharing 
as well as program eligibility. We found the top 10% of 
enrollees accounted for 64% to 66% of program expendi-
tures, and the top 1% for 20% to 24.7%, throughout this 
period. These findings are broadly consistent with previous 
studies examining the distribution of health expenditures 
among children. Consistent with previous literature, we find 
that non-Hispanic whites and those with chronic diseases are 
more likely to be high utilizers,4,5 and that infants and older 
adolescents are the age groups most likely to have the high-
est expenditures.4,23 We additionally find that older adoles-
cents may be most likely to persist in the highest percentile 
for 3 or more years.
Our results generally support arguments of Kenney et al 
that policies like nominal increases in cost sharing are likely 
to have minimal effectiveness in terms of cost containment.5 
Our previous work has suggested cost sharing discouraged 
re-enrollment10 and modestly reduced or slowed growth in 
the utilization of some health services,12,16 but results here 
suggest that they did little to slow utilization among high 
utilizers. Our results also support earlier work indicating that 
average expenditures increased following the expansion in eli-
gibility,13 but we additionally found that increases among the 
top 1% were disproportionately higher in the post-expansion 
period, leading to further cost concentration.
Although we agree that cost-containment approaches 
should focus on “strategies that target Medicaid/CHIP spend-
ing among children in the upper spending decile,”5 these 
strategies must be carefully selected. For example, targeting 
popular “wasteful” services like non-emergent ED use may 
not play a major role in reducing costs, as ED use that did not 
result in an inpatient admission accounts for only a small 
share of spending by high-cost utilizers. Better management 
of chronic diseases may be useful in limiting costs among the 
top decile, but is unlikely to help with reducing costs among 
the top percentile, given its small association with being in, 
or persisting in, the top 1%.
Finally, we identify the most common reasons for inpa-
tient stays among the top 1%, and broadly categorize them 
as potentially preventable versus not as a way of providing 
some guidance to policy makers as to where attempts at 
cost containment could start. This is presented in Table 4. 
The large majority of inpatient stays appear to be due to 
“non-preventable” acute health events. A small fraction of 
Table 2. Characteristics of ALL Kids Enrollee Months by 
“Non–High-Cost” and “High-Cost” Status.
90% Top 10% Top 1%
 N = 868 166 N = 153 211 N = 10 213
Age, y
 0-1 0.7 1.2 4.5
 2-4 8.5 7.3 8.2
 5-8 17.9 13.6 9.3
 9-12 27.3 22.3 15.7
 13-16 26.4 25.6 23.5
 17-19 19.2 30.0 38.8
Male 50.9 49.9 46.9
Race
 Caucasian 57.1 70.5 67.5
 African 
American
35.7 24.1 26.5
 Other/
unknown
7.2 5.5 6.0
Fee code
 Low fee 61.4 61.1 59.5
 Fee 35.3 35.2 36.4
 No fee 0.6 0.8 0.9
 Expansion 2.7 2.9 3.3
Rural/urban
 Urban 64.5 63.0 67.1
 Large rural 
town
12.3 13.4 12.4
 Small rural 
town
12.5 12.7 10.8
 Isolated rural 9.2 9.6 8.3
 Unknown 1.4 1.2 1.3
Chronic disease 17.6 44.7 63.1
Previous 
enrollment
57.7 75.5 73.1
Previous top 10% 16.0 42.1 50.8
Previous top 1% 0.9 5.2 1.6
Note. Pooled data for 1999 to 2011 are used. “High-cost status” is based 
on expenditures in that fiscal year only. Enrollees may have high-cost 
status in multiple fiscal years.
6 INQUIRY 
Table 3. Multivariable Logistic Regression for Characteristics Associated With Being a High-Cost Utilizer.
Top 10% Top 1% Top 1% persistent
 Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
Age, years
 0-1 Reference Reference Reference
 2-4 −7.9 −13.6 −3.1 −4.0 −0.5 −1
[−8.8, −7.0] [−14.7, −12.5] [−3.5, −2.7] [−4.4, −3.5] [−0.7, −0.3] [−1.4, −0.8]
 5-8 −9.1 −16.0 −3.4 −4.3 −0.01 −0.8
[−10.0, −8.2] [−17.1, −14.9] [−3.8, −3.1] [−4.7, −3.8] [−0.03, −0.004] [−1.0, −0.5]
 9-12 −8.3 −16.3 −3.4 −4.2 0.01 −0.7
[−9.2, −7.4] [−17.4, −15.1] [−3.8, −3.0] [−4.7, −3.8] [−0.005, 0.03] [−1, −0.4]
 13-16 −6.4 −15.0 −3.1 −4.1 0.4 −0.7
[−7.3, −5.4] [−16.1, −13.9] [−3.6, −2.8] [−4.5, −3.6] [0.2, 0.6] [−0.9, −0.4]
 17-19 1.1 −9.6 −2.5 −3.6 −0.07 −1.3
[0.1, 2.0] [−10.7, −8.4] [−2.8, −2.1] [−4.0, −3.1] [−0.2, 0.1] [−1.6, −1]
Male −0.9 −0.9 −0.1 −0.1 −0.06 −0.01
[−1.1, −0.7] [−1.1, −0.8] [−0.1, −0.1] [−0.1, −0.1] [−0.1, −0.01] [−0.01, −0.07]
Race
 Caucasian Reference Reference Reference
 African American −7.0 −5.9 −0.2 −0.2 −1 −0.6
[−7.2, −6.8] [−6.0, −5.7] [−0.2, −0.2] [−0.2, −0.1] [−1, −0.9] [−0.6, −0.6]
 Other/unknown −5.3 −4.4 −0.1 −0.1 −0.8 −0.5
[−5.6, −5.0] [−4.7, −4.1] [−0.2, −0.1] [−0.2, −0.1] [−0.9, −0.7] [−0.6, −0.4]
Fee code
 Low fee Reference Reference Reference
 Fee −0.3 −0.8 0.1 −0.1 −0.07 −0.15
[−0.5, −0.2] [−1.0, −0.7] [−0.1, 0.1] [−0.1,0.1] [−0.1, −0.03] [−0.18, −0.12]
 No fee 6.3 3.5 0.2 0.1 1.1 0.2
[4.8, 7.7] [2.3, 4.6] [−0.1, 0.5] [−0.1, 0.3] [0.5, 1.5] [−0.01, 0.5]
 Expansion 0.7 −0.2 0.1 0.1 — —
[0.2, 1.1] [−0.6, 0.2] [−0.1, 0.2] [−0.1, 0.1] — —
Rural/urban
 Urban Reference Reference Reference
 Large rural town 0.2 0.3 −0.1 −0.1 0.002 0.002
[−0.1, 0.5] [0.7, 0.5] [−0.1, −0.1] [−0.1, −0.1] [−0.07, 0.08] [−0.03, 0.06]
 Small rural town −0.4 −0.4 −0.1 −0.1 −0.1 −0.06
[−0.7, −0.2] [−0.6, −0.1] [−0.2, −0.1] [−0.1, −0.1] [−0.1, −0.02] [−0.01, −0.003]
 Isolated rural 0.1 0.1 −0.1 −0.1 −0.005 −0.03
[−0.3, 0.3] [−0.2, 0.3] [−0.2, −0.1] [−0.1, −0.1] [−0.01, 0.003] [−0.09, 0.01]
 Unknown −0.7 −0.5 0.1 0.1 −0.02 −0.01
[−1.5, −0.1] [−1.1, 0.1] [−0.1, 0.2] [−0.1, 0.1] [−0.3, 0.02] [−0.06, 0.04]
Chronic disease 15.2 11.9 1.1 0.9 0.2 1.5
[15.0, 15.4] [11.7, 12.1] [1.1, 1.1] [0.9, 0.9] [0.2, 0.2] [1.4, 1.5]
Previous enrollment — 3.7 — 0.1 0.2
 [3.4, 3.8] [0.1, 0.1] [0.1, 0.2]
Previous top 10% — 8.9 — —  
 [8.7, 9.1]  
Previous top 1% — — — 1.2  
 [1.1, 1.2]  
Previous top % count 0.5
 [0.5, 0.53]
Note. The 95% confidence intervals are given in brackets. Pooled data for 1999 to 2011 are used, N = 1 021 377 enrollee-months. Top 10% of 1% is based 
on expenditures in that fiscal year only. Enrollees may have high-cost status in multiple fiscal years. Persistent 1% is based on being in the category for at 
least 3 subsequent years. Standard errors are clustered to account for repeat observations for the same child.
Sen et al 7
potentially preventable cases are outside the scope of ALL 
Kids to address—for example, as the program does not 
cover non-minor pregnant women, the program cannot 
seek to improve prenatal care in an effort to reduce the risk 
of low birth weight. However, approximately 14% to 15% 
of inpatient stays that stem from causes like asthma, 
chronic disease complications, nutrition deficiency, or 
mood/anxiety disorders might be prevented with better 
access to preventive services, outpatient services, or better 
case management.
The study has several limitations. Because it is based on 
a free-standing CHIP program, distinct from the state’s 
Medicaid program, results may not be generalized to all 
publicly insured children. It focuses on claims-based 
expenditures from the program’s point of view, and does 
not inform on out-of-pocket expenditures for children. We 
have little information on “high-expenditure” status of 
enrollees who leave ALL Kids for Medicaid or private 
insurance. We also have no information on prenatal health 
behaviors of mothers whose infants fall in the high-expen-
diture category. We present a broad generalization of the 
categories of inpatient use that may be considered “pre-
ventable,” but cannot do an in-depth clinical review of indi-
vidual records to further verify this. Finally, we cannot 
comment on the extent to which high-cost utilizers experi-
ence improvements in health and quality of life as a result 
of consuming higher levels of health services.
Overall, this study suggests that to effectively control 
public insurance program costs, more in-depth attention 
should be given to health services utilized by high-cost 
enrollees. Using information on socio-demographic charac-
teristics, health service access and patterns of utilization, tar-
geted interventions should be developed to reduce the use of 
avoidable care by the highest cost utilizers.
Appendix A
The Gini coefficient (G) is a unit-independent measure of 
statistical dispersion. It is frequently used in the analysis 
of inequality of income or expenditures. Mathematically, 
G is the ratio of the area between the expenditure distribu-
tion curve (Lorenz curve) and the line of equal distribu-
tion (45° straight line)—denoted as “A” in diagram 
below—to the area under the equal distribution curve—
denoted as (A + B). Each (x, y) point on the curve means 
that the bottom x% of enrollees account for y% of the 
wealth. The 45° straight line represents all points where x 
= y (such that lowest 10% of enrollees account for 10% of 
expenditure, lowest 20% account for 20% of expenditure, 
and so forth). G can hypothetically range from 0 to 1; 0 
represents the “most equal” situation—each person 
accounts for an equal share of expenditure and the Lorenz 
curve is identical to the 45° line, and 1 represents the most 
unequal distribution, where just one person accounts for 
all expenditure.
Table 4. Most Common Reasons for Inpatient Stays Among Top Percentile.
Fiscal year Most common inpatient primary diagnoses (upcoded via Clinical Classifications Software) in each year among top 1%
1999 Intracranial injury (7.2%) Pneumonia (7.1%) Mood disorders (3.3%) Appendicitis (3.2%) Epilepsy/convulsions (2.8%)
2000 Pneumonia (4.1%) Cystic fibrosis (3.8%) Urinary tract infection 
(2.5%)
Congestive heart 
failure (2.4%)
Other injury (2.4%)
2001 Mood disorders (4.5%) Pneumonia (4.1%) Other lower 
respiratory (3.3%)
Low birth weight 
(3.1%)
Epilepsy/convulsions 
(3.0%)
2002 Pneumonia (5.0%) Mood disorders (4.0%) Low birth weight (3.9%) Leukemias (3.9%) Pleurisy (3.5%)
2003 Low birth weight (7.8%) Mood disorders (6.4%) Pneumonia (4.3%) Diabetes mellitus 
With coma (3.7%)
Schizophrenia (3.1%)
2004 Mood disorders (12.7%) Attention-deficit (5.2%) Diabetes mellitus with 
coma (4.6%)
Pneumonia (2.6%) Epilepsy/convulsions 
(2.5%)
2005 Mood disorders (6.0%) Low birth weight (3.8%) Pneumonia (3.7%) Asthma (2.6%) Schizophrenia (2.4%)
2006 Low birth weight (6.8%) Asthma (3.5%) Pneumonia (3.4%) Leukemias (3.0%) Intracranial injury (2.6%)
2007 Low birth weight (6.3%) Asthma (5.4%) Epilepsy/convulsions 
(3.8%)
Skin infection (3.6%) Pneumonia (3.5%)
2008 Low birth weight (9.5%) Mood disorders (5.9%) Leukemias (4.0%) Skin infection (3.4%) Other perinatal dx (3.3%)
2009 Mood disorders (9.4%) Low birth weight (8.4%) Asthma (3.3%) Pneumonia (3.2%) Pleurisy (3.1%)
2010 Mood disorders (13.2%) Low birth weight 
(11.2%)
Other perinatal dx 
(6.5%)
Leukemias (4.0%) Attention-deficit (2.6%)
2011 Low birth weight (12.5%) Mood disorders 
(11.6%)
Other perinatal dx 
(6.9%)
Impulse control 
disorder (2.8%)
Attention-deficit (2.6%)
Note. Data are based on a single primary diagnosis per child per day or per stay.
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Figure A1. Gini coefficients for health expenditure distribution.
Percentage of Diagnosis for Inpatient Stays Among Highest 
1% of Enrollees Due to “Preventable” and “Not Preventable 
Conditions,” 1999-2011.
% Preventable 
by ALL kidsa
% Preventable, outside 
scope of ALL kidsb
% Not 
preventablec
1999
n = 118
16 2 82
2000
n = 152
14 1 85
2001
n = 163
15 1 83
2002
n = 168
14 1 85
2003
n = 180
14 1 84
2004
n = 189
14 1 85
2005
n = 184
14 1 85
2006
n = 176
9 1 90
2007
n = 171
10 1 89
2008
n = 186
13 1 86
2009
n = 185
13 1 86
(continued)
% Preventable 
by ALL kidsa
% Preventable, outside 
scope of ALL kidsb
% Not 
preventablec
2010
n = 197
13 1 86
2011
n = 194
15 1 84
Note. This categorization is based on over 200 types of claims that were 
the primary reason of inpatient stays among the top 1%. The rows may 
not add up to 100% due to rounding.
aIncludes conditions such as mood disorders, anxiety disorders, attention-
deficit, chronic disease complications, nutrition deficit, anemia, asthma, 
influenza, upper respiratory infection, otitis media, tonsillitis.
bIncludes hypertension during pregnancy, low birth weight.
cIncludes conditions such as malignancy, organ anomaly/disorder, 
organ failure, acute medical conditions (acute cardiovascular disease, 
appendicitis, injury, fractures, etc), infection.
Appendix B (continued)
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